HUALAN BIOLOGICAL
00200713.440.30% ( -0.04 )
HUALAN BIOLOGICAL (002007)
Hualan Biological Engineering Inc., together with its subsidiaries, engages in the research, development, production, and sale of biological products in China a...
- Open
- 13.43
- High
- 13.73
- Low
- 13.40
- Prev. Close
- 13.48
- Volume
- 190.10K
- Turnover
- 257.96M
- Avg Price
- 13.57
- Bid/Ask Ratio
- --
- Amplitude
- 2.45%
- 52wk High
- 17.39
- Volume Ratio
- 0.88
- Turnover Ratio
- 1.04%
HUALAN BIOLOGICAL Analyst Rating
View MoreForecast & Rating
May 7, 2026Price forecast
¥18.0434.21%
Forecast & RatingStrong buy
7analysts
- Strong buy71.43%
- Buy14.29%
- Hold14.29%
- Sell0.00%
- Strong sell0.00%
News
- Zhitong · Nov 3, 2025 at 11:44 PM
Afternoon flu concept shows partial fluctuations, Hualan Vac rises over 10%
- Zhitong · Oct 23, 2025 at 06:54 PM
Overview of A-share dividends and stock distributions: 9 stocks have their equity registration today
- 36Kr · Sep 3, 2025 at 10:21 PM
The flu vaccine has a "freezing point price" of 5.5 yuan
- Zhitong · Aug 27, 2025 at 06:31 AM
HUALAN BIOLOGICAL released its performance for the first half of the year, with a net profit attributable to the parent company of 516 million yuan, a year-on-year increase of 17.19%
- Zhitong · Aug 21, 2025 at 02:57 AM
HUALAN BIOLOGICAL's subsidiary genetic engineering company increased its capital to 300 million, an increase of 50%
- Zhitong · Jul 28, 2025 at 12:28 AM
Zhonghui Biological: Holding high-end vaccine single product performance surges, yet still struggling to break the industry's involution dilemma?
